Tilray Brands, Inc. - 17 Aug 2021 Form 3 Insider Report for MedMen Enterprises, Inc.

Role: 10%+ Owner
Signature: /s/ Mitchell Gendel, authorized officer
Issuer symbol: N/A
Transactions as of: 17 Aug 2021
Net transactions value: $0
Form type: 3
Filing time: 17 Dec 2021, 15:42:13 UTC
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	917,832	$3.72	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	265,152	$4.29	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	3,671,329	$3.72	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	1,060,606	$4.29	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	1,350,309	$3.16	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	390,089	$3.64	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	1,687,492	$1.01	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	487,497	$1.17	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	53,139,307	$0.1529	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	10,627,861	$0.1529	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	21,255,723	$0.1529	See Footnote	F1
holding	MMNFF	Warrant	17 Aug 2021	Class B Subordinate Voting Shares	40,413,468	$0.1608	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The convertible notes and warrants are owned directly by Superhero Acquisition L.P. ("LP"). Superhero Acquisition Corp. ("Corp.") is the general partner of LP. Tilray, Inc. ("Tilray") owns approximately two-thirds of the outstanding equity interests in Corp. and approximately two-thirds of the outstanding equity interest in LP. Accordingly, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Tilray may be deemed a beneficial owner with respect to securities held of record by LP and has shared voting and investment power with respect to such securities. Tilray disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Content

The convertible notes and warrants are owned directly by Superhero Acquisition L.P. ("LP"). Superhero Acquisition Corp. ("Corp.") is the general partner of LP. Tilray, Inc. ("Tilray") owns approximately two-thirds of the outstanding equity interests in Corp. and approximately two-thirds of the outstanding equity interest in LP. Accordingly, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Tilray may be deemed a beneficial owner with respect to securities held of record by LP and has shared voting and investment power with respect to such securities. Tilray disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Remarks:

This Form 3 is the second of two Form 3s filed relating to the same event. This Form 3 has been split into two filings because there are more than 30 derivative securities beneficially owned, and the SEC's EDGAR filing system limits a single Form 3 to a maximum of 30 rows per table. This filing relates to transactions that occurred on August 17, 2021, which were previously disclosed by Tilray in its Current Report on Form 8-K filed on August 18, 2021. As of the date of this filing, Tilray has not executed any transactions in MedMen Enterprises, Inc. securities since August 17, 2021.